Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Evotec SEEVO-8.781.941.5517.17-16.25%-7.51%71.21$3.77$90.738,293$4.48

Detail of Evotec SE

 
CEO
Dr. Mario Polywka DPHIL, Ph.D.
Employees
5007
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$2B

Company details

Evotec SE Sponsored ADR represents shares in Evotec SE, a leading biotechnology company headquartered in Germany. Renowned for its innovative approach, Evotec SE specializes in drug discovery and development across several therapeutic areas, including neuroscience, oncology, and infectious diseases. The company leverages advanced technologies and data-driven solutions to accelerate the drug discovery process, aiming to provide novel content, platforms, and capabilities to its partners in the pharmaceutical and biotechnology sectors. As a Sponsored American Depository Receipt (ADR), it allows U.S. investors to gain exposure to Evotec SE without the complexities of investing directly in foreign stocks. This ADR facilitates access through platforms and brokerages familiar to U.S. traders, thus playing a crucial role in increasing the company's investor base outside Europe. In the global finance market, Evotec SE is recognized for its commitment to transforming the scientific innovation landscape by fostering strategic collaborations and investing in disruptive technologies.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$777.05M
Cost of goods (CoG)
-$670.60M
Gross profit (GP)
$106.45M
Operating expense (OE)
-$229.98M
Research and development (R&D)
-$61.29M
General and administrative (G&A)
-$180.42M
Other (OTH)
$11.74M
Operating income (OI)
-$98.72M
Other income expense (OIE)
-$96.86M
Pretax income (PI)
-$202.14M
Tax (TAX)
$30.77M
Net income (NI)
-$171.37M
Evotec SE
EVO • XNGS • US
$4.48
-2.65 (-37.17%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.5683
Payout ratio
0.00%
EPS
-$0.51
Margin profit
-22.05%
52 week low
$2.90
52 week high
$7.87
50-day simple moving average
$0.00
200-day simple moving average
$3.77
Percent held by insiders
0.00%
Percent held by institutions
2.52%
Dividend yield
12.41%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
EVO -37.17%
eps change
EVO 0.00%